Does red ginseng ameliorate liver damage caused by obstructive jaundice? : an experimental study

Year 2021, Volume: 4 Issue: 2, 233 - 239, 28.03.2021

Abdullah Durhan Koray Koşmaz Abdullah Şenlikci Ender Ergüder Marlen Süleyman Mehmet Esat Duymuş Yusuf Murat Bağ Mevlüt Recep Pekcici Mehmet Şeneş İlknur Alkan Kuşabbi Eylem Pınar Eser Sema Hücümenoğlu

https://doi.org/10.32322/jhsm.900023

Cited By: 2

Abstract

Aim: This experimental study aimed to evaluate the hepatoprotective effect on obstructive jaundice (OJ) of oral red ginseng (RG) extract, which is known to have anti-inflammatory and antioxidant properties.
Methods: The rats were randomly separated into 3 groups of 10 rats: the sham group, the control group, and the treatment group. In Group 1 (sham), the common bile duct (CBD) was identified but no ligation or transection was performed. In Group 2 (control), the CBD was identified and ligation and transection were performed, but no treatment was given. In Group 3 (RG group), CBD ligation and transection were performed, then RG extract was administered via an orogastric tube at a dose of 100 mg/ kg/day for 10 days. After 10 days, blood samples were taken for biochemical analysis, and liver tissue samples for biochemical and histopathological analysis.
Results: Significantly higher serum albumin levels and lower serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were determined in the RG group than in the control group (p = 0.028, p = 0.001 and p = 0.034, respectively). In the oxidative stress parameters, malondialdehyde (MDA) levels and catalase (CAT) levels were significantly different between the RG group and control group (p = <0.001 for each). Total sulfhydryl (T-SH) was not at a statistically significant level, although it was high and approached the value of the sham group ( p = 0.076). In the histopathological evaluation, the RG group had statistically significantly lower scores in all parameters compared to the control group (p<0.05).
Conclusion: The results of this study showed that RG has a strong hepatoprotective effect as a result of its anti-inflammatory and antioxidant properties.

Keywords

Red ginseng, obstructive jaundice, anti-inflammatory properties, antioxidant properties, hepatoprotective effects

References

• 1. González-Chávez A, Elizondo-Argueta S, Gutiérrez-Reyes G, León-Pedroza JI. Pathophysiological implications between chronic inflammation and the development of diabetes and obesity. Cir Cir 2011; 79: 209-16.
• 2. Tracy RP. Emerging relationships of inflammation, cardiovascular disease and chronic diseases of aging. Int J Obes Relat Metab Disord 2003; 27: 29-34.
• 3. Allavena P, Germano G, Marchesi F, Mantovani A. Chemokines in cancer related inflammation. Exp Cell Res 2011; 317: 664-73.
• 4. Baeck C, Tacke F. Balance of inflammatory pathways and interplay of immune cells in the liver during homeostasis and injury. EXCLI J 2014; 13: 67-81.
• 5. Scott-Conner CE, Grogan JB. The pathophysiology of biliary obstruction and its effect on phagocytic and immune function. J Surg Res 1994; 57: 316-36.
• 6. Moran M, Oruc MT, Ozmen MM, et al. Effect of erythropoietin on oxidative stress and liver injury in experimental obstructive jaundice. Eur Surg Res 2009; 43: 228-34.
• 7. KoŞmaz K, Durhan A, SÜleyman M, et al. The Effect of Ankaferd Blood Stopper on Liver Damage in Experimental Obstructive Jaundice. Turk J Med Sci 2020. doi:10.3906/sag-2007-298.
• 8. Kismet K, Sabuncuoglu MZ, Kilicoglu SS, et al. Effect of propolis on oxidative stress and histomorphology of liver tissue in experimental obstructive jaundice. Eur Surg Res 2008; 41: 231-7.
• 9. Ahuja A, Kim JH, Kim JH, Yi YS, Cho JY. Functional role of ginseng-derived compounds in cancer. J Ginseng Res 2018; 42: 248-54.
• 10. Huu Tung N, Uto T, Morinaga O, Kim YH, Shoyama Y. Pharmacological effects of ginseng on liver functions and diseases: a minireview. Evid Based Complement Alternat Med 2012; 2012: 173297.
• 11. Abdelfattah-Hassan A, Shalaby SI, Khater SI, El-Shetry ES, Abd El Fadil H, Elsayed SA. Panax ginseng is superior to vitamin E as a hepatoprotector against cyclophosphamide-induced liver damage. Complement Ther Med 2019; 46: 95-102.
• 12. Kim JH, Yi YS, Kim MY, Cho JY. Role of ginsenosides, the main active components of Panax ginseng, in inflammatory responses and diseases. J Ginseng Res 2017; 41: 435-43.
• 13. Wasowicz W, Nève J, Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem 1993; 39: 2522-6.
• 14. Hadwan MH. Simple spectrophotometric assay for measuring catalase activity in biological tissues. BMC Biochem 2018; 19: 7.
• 15. Taylan E, resmi h. The Analytical Performance of a Microplate Method for Total Sulfhydryl Measurement in Biological Samples. Turk J Biochem 2010; 35: 275-8.
• 16. Ishak KG. Pathologic features of chronic hepatitis. A review and update. Am J Clin Pathol 2000; 113: 40-55.
• 17. Padillo FJ, Cruz A, Navarrete C, et al. Melatonin prevents oxidative stress and hepatocyte cell death induced by experimental cholestasis. Free Radic Res 2004; 38: 697-704.
• 18. Chuang JH, Chang NK, Huang CC, et al. Biliary intervention augments chemotactic reaction and aggravates cholestatic liver injury in rats. J Surg Res 2004; 120: 210-8.
• 19. Cantürk NZ, Canturk Z, Utkan NZ, et al. Cytoprotective effects of alpha tocopherol against liver injury induced by extrahepatic biliary obstruction. East Afr Med J 1998; 75: 77-80.
• 20. Unal Y, Tuncal S, Kosmaz K, et al. The Effect of Calcium Dobesilate on Liver Damage in Experimental Obstructive Jaundice. J Invest Surg 2019; 32: 238-44.
• 21. Ljubuncic P, Tanne Z, Bomzon A. Evidence of a systemic phenomenon for oxidative stress in cholestatic liver disease. Gut 2000; 47: 710-6.
• 22. Dilektasli E, Ozmen MM, Gundogdu E, Dizen H, Besler HT, Ozogul C. The effects of obstructive jaundice on the brain: An experimental study. Asian J Surg 2016; 39: 155-63.
• 23. Lv Y, Yue J, Gong X, et al. Spontaneous remission of obstructive jaundice in rats: Selection of experimental models. Exp Ther Med 2018; 15: 5295-301.
• 24. Gillis CN. Panax ginseng pharmacology: a nitric oxide link? Biochem Pharmacol 1997; 54: 1-8.
• 25. Xu XF, Gao Y, Xu SY, et al. Remarkable impact of steam temperature on ginsenosides transformation from fresh ginseng to red ginseng. J Ginseng Res 2018; 42: 277-87.
• 26. Chang-Xiao L, Pei-Gen X. Recent advances on ginseng research in China. J Ethnopharmacol 1992; 36: 27-38.
• 27. Hasegawa H. Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid. J Pharmacol Sci 2004; 95: 153-7.
• 28. Kim KH, Lee D, Lee HL, Kim CE, Jung K, Kang KS. Beneficial effects of Panax ginseng for the treatment and prevention of neurodegenerative diseases: past findings and future directions. J Ginseng Res 2018; 42: 239-47.
• 29. Lü JM, Yao Q, Chen C. Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol 2009; 7: 293-302.
• 30. Im DS. Pro-Resolving Effect of Ginsenosides as an Anti-Inflammatory Mechanism of Panax ginseng. Biomolecules 2020; 10: 444.
• 31. Karakus E, Karadeniz A, Simsek N, et al. Protective effect of Panax ginseng against serum biochemical changes and apoptosis in liver of rats treated with carbon tetrachloride (CCl4). J Hazard Mater 2011; 195: 208-13.
• 32. Hong SH, Suk KT, Choi SH, et al. Anti-oxidant and natural killer cell activity of Korean red ginseng (Panax ginseng) and urushiol (Rhus vernicifera Stokes) on non-alcoholic fatty liver disease of rat. Food Chem Toxicol 2013; 55: 586-91.
• 33. Abdel-Wahhab PM, Gamil K, Elkady A, el-nekeety A, Naguib K. Therapeutic Effects of Korean Red Ginseng Extract in Egyptian Patients with Chronic Liver Diseases. J Ginseng Res 2011; 35: 69-79.